targeted therapy for chemotherapy-induced peripheral neuropathy and cognitive dysfunction (Korysso therapeutics/Magnolia Tejas)

N/A

Report date: 2025/01/26 17:17:35
NME

Base Information

Drug Nametargeted therapy for chemotherapy-induced peripheral neuropathy and cognitive dysfunction (Korysso therapeutics/Magnolia Tejas)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCognition DisordersPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMagnolia Tejas Corp
China Registration ClassN/A

Develop Information

Active CompaniesMagnolia Tejas Corp
Inactive CompaniesN/A
Active IndicationsCognition DisordersPeripheral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A